Ambry Genetics

12/19/2025

You want the best information for your practice, but it's hard to keep up with the new discoveries and changing guidelines. and we've done the work for you! We share our in these that highlight what you need to know:
https://hubs.ly/Q03YD4Jt0

12/18/2025

Join us for the third annual research round-up!
Look back at 2025 research with a fast, focused review of the top ten most impactful genetics papers of the year and what they mean for real-world clinical decision making. Ambry’s experts will break down key findings, highlight clinical implications across oncology and rare disease, and share practical guidance you can apply to your practice.
Register today! https://hubs.ly/Q03YD32x0

12/18/2025

We’re thrilled to highlight Adela Rodríguez-Hernández, MD, in our Making Waves series, dedicated to spotlighting the extraordinary work of healthcare providers and researchers who are creating ripple effects of impact in their communities.
As a research fellow in the Cancer Genetics and Prevention group at Dana-Farber Cancer Institute—trained as a medical oncologist in Spain and specializing in hereditary cancer and translational genomics—Dr. Rodríguez-Hernández is often asked how to counsel patients who carry rare pathogenic variants, particularly when evidence is limited or outdated. In this blog, she explores results from a newly published study in Gynecologic Oncology, where a decade of clinical testing data was analyzed to better characterize cancer patterns among individuals with SMARCA4 gPVs, in order to help address long-standing gaps in counseling, surveillance, and prevention.
The waves these extraordinary scientists make extend far beyond a single patient—they touch families, futures, and generations to come.

🌊 Dive into the research: https://hubs.ly/Q03YD35t0

12/17/2025

Hereditary cancer testing can make a big impact—not just for patients, but for their families too!

At Mercy’s Center for Precision Medicine in St. Louis, one patient’s journey shows how the Ambry CARE Program® identified him as eligible for hereditary cancer testing. That testing provided important information for his care and ultimately helped save his daughter’s life.
This story underscores the importance of high-risk patient identification and the power of strong partnerships that put patients at the center.
Check out the full story here: https://hubs.ly/Q03YtjZp0

On Demand Arts, Culture & Education Programming

12/16/2025

Ambry is the proud recipient of three new Comparably awards. In addition to Best Company Compensation and Best Company Culture, we want to give a special shout out to Tom Schoenherr who was recognized in the Best CEOs category.

12/16/2025

Haaniya Mallick, MS, CGC, joins us in the Gene Scene to explore KCNQ1-related long QT Syndrome (LQTS), including autosomal dominant LQTS1, autosomal-recessive LQTS1 (AR-LQTS), and Jervell and Lange-Nielsen syndrome (JLNS). Dive deeper:
https://hubs.ly/Q03YkpCC0

12/15/2025

We want to wish everyone a merry and bright holiday season, filled with warmth, light, and love.

12/15/2025

Are you part of the ? We are proud of our , and we want to make sure you have the best information for your practice.
Check out our Provider Resources, including Research for Your Practice, which highlight significant research findings that are relevant for you.
https://hubs.ly/Q03Y8Jyd0

12/12/2025

Are you part of the ? We are proud of our , and we know the path forward is always smoother with . We want to highlight some resources we have available for you!
Looking for continuing education that also awards CEUs? Check out our EducateNext webinars! https://hubs.ly/Q03X_LX-0

12/11/2025

Proud to share a recent case report in Frontiers in Oncology that describes the use of paired DNA and RNA testing to uncover a deep intronic PTEN variant in a patient with clinical Cowden syndrome who would have received a negative report with DNA-only testing. Many thanks to our collaborators at Fox Chase Cancer Center for their commitment to patient care and to sharing their experience.
https://hubs.ly/Q03XR28q0

12/10/2025

Have you ever wondered about the differences between Progeny and the Ambry CARE Program®? Dr. Melissa Frey explains which solution may be right for you. Dive deeper:
https://blog.ambrygen.com/ambry/post/410/from-primary-care-to-oncology-digital-risk-tools-in-practice

12/09/2025

Ambry celebrates the vital role of oncology navigators in cancer care this National Navigator Day. National Navigator Day, specifically National Oncology Navigator Day, honors the compassionate professionals who help guide cancer patients through their complex care journeys. Navigators are vital advocates in oncology care who offer crucial support, such as helping patients navigate their treatments and access valuable resources. Thank you for all you do!